Share Price and Basic Stock Data
Last Updated: October 28, 2025, 1:52 pm
| PEG Ratio | -30.18 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Expleo Solutions Ltd operates in the IT Consulting and Software sector, with its share price reported at ₹1,027 and a market capitalization of ₹1,594 Cr. The company has shown robust revenue growth, recording sales of ₹903 Cr for the fiscal year ending March 2023, which rose to ₹965 Cr for March 2024, and is projected to reach ₹1,025 Cr for March 2025. The quarterly sales figures demonstrate consistent performance, with the latest quarter (Sep 2023) reporting sales of ₹234 Cr, a slight increase from ₹231 Cr in Mar 2023. The company has maintained a healthy operating profit margin (OPM) of 11%, indicative of its ability to manage expenses effectively against its revenue stream. Additionally, Expleo’s reserves stood at ₹620 Cr, reflecting a solid foundation for operational and strategic investments. This growth trajectory places Expleo favorably within the competitive landscape of IT consulting, where revenue growth rates typically vary widely but often hover around 10-15% for established players in the sector.
Profitability and Efficiency Metrics
Expleo Solutions Ltd reported a net profit of ₹103 Cr for the fiscal year ending March 2025, demonstrating a robust return on equity (ROE) of 16.3% and a return on capital employed (ROCE) of 21.5%. These figures are indicative of efficient capital utilization and strong profitability relative to shareholder equity. The company’s profit before tax for Mar 2025 stood at ₹139 Cr, while the net profit margin was recorded at 10.07%, reflecting effective cost management strategies. The interest coverage ratio (ICR) was exceptionally high at 54.75x, suggesting that the company can easily cover its interest obligations, which stood at a modest ₹3 Cr for the year. The cash conversion cycle (CCC) is reported at 79 days, which is manageable and aligns well with industry standards, indicating efficient management of receivables and payables. Overall, Expleo’s profitability metrics position it as a strong contender in the IT consulting space, with a capacity to sustain its operations and invest in growth initiatives.
Balance Sheet Strength and Financial Ratios
The balance sheet of Expleo Solutions Ltd reflects a solid financial position, with total assets reported at ₹831 Cr and total liabilities at ₹831 Cr as of March 2025, indicating a balanced structure. The company’s reserves have steadily increased, from ₹515 Cr in March 2023 to ₹620 Cr in March 2025. Borrowings remain low at ₹30 Cr, underscoring the company’s conservative financing strategy. The price-to-book value ratio stood at 1.94x, which is reasonable compared to sector averages, suggesting that the stock is fairly valued relative to its net assets. Additionally, the current ratio of 3.90x indicates strong liquidity, enabling the company to meet its short-term obligations comfortably. Expleo has also maintained a healthy cash EPS of ₹91.85, reinforcing its ability to generate cash flow from operations. Overall, these financial ratios highlight the company’s strong fiscal health and its ability to navigate potential downturns in the market.
Shareholding Pattern and Investor Confidence
As of March 2025, the shareholding pattern of Expleo Solutions Ltd reveals a dominant promoter stake of 71.05%, which instills confidence among investors regarding strategic direction and operational stability. The public holds 28.03% of the shares, while foreign institutional investors (FIIs) and domestic institutional investors (DIIs) account for 0.09% and 0.84%, respectively. The increase in the number of shareholders from 20,671 in March 2023 to 28,556 in March 2025 indicates growing interest in the company’s stock. However, the low FII participation may reflect a cautious approach from international investors towards the IT consulting sector’s volatility. The promoter’s significant stake suggests a long-term commitment to the company’s growth strategy, while the gradual increase in public shareholding may signal positive sentiment in the market. This combination of ownership dynamics reflects a stable investor base, which is crucial for maintaining stock performance and attracting further investment.
Outlook, Risks, and Final Insight
Expleo Solutions Ltd is positioned to capitalize on the growing demand for IT consulting and software solutions, with a focus on innovation and operational efficiency. However, risks such as fluctuating demand in the IT sector, potential economic downturns, and increased competition from both domestic and international firms could impact future growth. Additionally, the reliance on a concentrated promoter stake may raise concerns about governance and decision-making. Nevertheless, the company’s solid financial metrics, strong profitability, and efficient management indicate resilience against market challenges. Should Expleo successfully diversify its client base and enhance its service offerings, it could further strengthen its market position. Conversely, failure to adapt to industry changes may hinder growth prospects. Overall, Expleo presents a compelling case for investment, contingent on its ability to navigate these risks and leverage its strengths in the competitive landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Expleo Solutions Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Visesh Infotecnics Ltd | 125 Cr. | 0.33 | 0.38/0.33 | 1.12 | 0.00 % | 2.21 % | 2.23 % | 1.00 | |
| Mudunuru Ltd | 33.0 Cr. | 10.4 | 10.4/4.43 | 0.25 | 0.00 % | 27.0 % | 90.7 % | 2.00 | |
| Naapbooks Ltd | 155 Cr. | 144 | 194/99.8 | 34.7 | 33.2 | 0.00 % | 23.6 % | 17.1 % | 10.0 |
| IB Infotech Enterprises Ltd | 35.2 Cr. | 275 | 310/140 | 27.3 | 19.0 | 0.36 % | 38.5 % | 35.4 % | 10.0 |
| Hit Kit Global Solutions Ltd | 6.15 Cr. | 1.27 | 1.73/0.91 | 55.9 | 2.52 | 0.00 % | 2.14 % | 2.15 % | 2.00 |
| Industry Average | 19,145.25 Cr | 562.81 | 143.29 | 119.01 | 0.53% | 14.92% | 20.95% | 6.84 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 212 | 220 | 240 | 231 | 225 | 234 | 250 | 255 | 252 | 259 | 258 | 256 | 260 |
| Expenses | 176 | 178 | 168 | 188 | 192 | 200 | 212 | 221 | 213 | 217 | 219 | 216 | 230 |
| Operating Profit | 37 | 42 | 72 | 43 | 33 | 34 | 38 | 34 | 39 | 42 | 39 | 40 | 30 |
| OPM % | 17% | 19% | 30% | 19% | 15% | 14% | 15% | 13% | 15% | 16% | 15% | 16% | 11% |
| Other Income | 1 | 1 | 13 | 4 | 2 | 2 | 11 | 2 | 2 | 13 | 3 | 5 | 7 |
| Interest | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 7 | 7 | 7 | 7 | 8 | 8 | 8 | 9 | 9 | 10 | 12 | 8 | 8 |
| Profit before tax | 31 | 36 | 77 | 39 | 26 | 27 | 41 | 26 | 31 | 44 | 28 | 36 | 28 |
| Tax % | 25% | 33% | 28% | 26% | 22% | 24% | 16% | 40% | 23% | 20% | 30% | 32% | 28% |
| Net Profit | 23 | 24 | 55 | 29 | 20 | 21 | 34 | 16 | 24 | 35 | 20 | 24 | 20 |
| EPS in Rs | 22.39 | 23.38 | 54.00 | 28.34 | 13.01 | 13.22 | 21.93 | 10.12 | 15.40 | 22.87 | 12.75 | 15.52 | 13.16 |
Last Updated: August 20, 2025, 11:00 am
Below is a detailed analysis of the quarterly data for Expleo Solutions Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 260.00 Cr.. The value appears strong and on an upward trend. It has increased from 256.00 Cr. (Mar 2025) to 260.00 Cr., marking an increase of 4.00 Cr..
- For Expenses, as of Jun 2025, the value is 230.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 216.00 Cr. (Mar 2025) to 230.00 Cr., marking an increase of 14.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 30.00 Cr.. The value appears to be declining and may need further review. It has decreased from 40.00 Cr. (Mar 2025) to 30.00 Cr., marking a decrease of 10.00 Cr..
- For OPM %, as of Jun 2025, the value is 11.00%. The value appears to be declining and may need further review. It has decreased from 16.00% (Mar 2025) to 11.00%, marking a decrease of 5.00%.
- For Other Income, as of Jun 2025, the value is 7.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 2.00 Cr..
- For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 28.00 Cr.. The value appears to be declining and may need further review. It has decreased from 36.00 Cr. (Mar 2025) to 28.00 Cr., marking a decrease of 8.00 Cr..
- For Tax %, as of Jun 2025, the value is 28.00%. The value appears to be improving (decreasing) as expected. It has decreased from 32.00% (Mar 2025) to 28.00%, marking a decrease of 4.00%.
- For Net Profit, as of Jun 2025, the value is 20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 24.00 Cr. (Mar 2025) to 20.00 Cr., marking a decrease of 4.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 13.16. The value appears to be declining and may need further review. It has decreased from 15.52 (Mar 2025) to 13.16, marking a decrease of 2.36.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:22 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 194 | 214 | 264 | 260 | 271 | 283 | 270 | 301 | 743 | 903 | 965 | 1,025 | 1,032 |
| Expenses | 155 | 177 | 210 | 219 | 231 | 230 | 217 | 231 | 618 | 703 | 816 | 859 | 882 |
| Operating Profit | 40 | 37 | 54 | 41 | 40 | 53 | 53 | 70 | 124 | 200 | 149 | 166 | 151 |
| OPM % | 20% | 17% | 20% | 16% | 15% | 19% | 20% | 23% | 17% | 22% | 15% | 16% | 15% |
| Other Income | 10 | 2 | 6 | 1 | 13 | 6 | 8 | 5 | 6 | 16 | 7 | 16 | 27 |
| Interest | 2 | 2 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 3 | 3 | 3 |
| Depreciation | 6 | 5 | 4 | 5 | 6 | 6 | 6 | 6 | 19 | 28 | 34 | 39 | 38 |
| Profit before tax | 42 | 32 | 56 | 37 | 48 | 54 | 54 | 68 | 110 | 186 | 120 | 139 | 137 |
| Tax % | 29% | 32% | 34% | 36% | 33% | 32% | 26% | 26% | 39% | 28% | 24% | 26% | |
| Net Profit | 30 | 22 | 37 | 24 | 32 | 36 | 40 | 50 | 68 | 134 | 90 | 103 | 100 |
| EPS in Rs | 29.26 | 20.53 | 34.68 | 22.29 | 29.86 | 33.79 | 38.92 | 49.20 | 66.01 | 130.59 | 58.27 | 66.52 | 64.30 |
| Dividend Payout % | 31% | 117% | 69% | 108% | 80% | 0% | 0% | 0% | 0% | 6% | 0% | 75% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -26.67% | 68.18% | -35.14% | 33.33% | 12.50% | 11.11% | 25.00% | 36.00% | 97.06% | -32.84% | 14.44% |
| Change in YoY Net Profit Growth (%) | 0.00% | 94.85% | -103.32% | 68.47% | -20.83% | -1.39% | 13.89% | 11.00% | 61.06% | -129.89% | 47.28% |
Expleo Solutions Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 31% |
| 3 Years: | 11% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 21% |
| 3 Years: | 14% |
| TTM: | 6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 16% |
| 3 Years: | -8% |
| 1 Year: | -22% |
| Return on Equity | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 21% |
| 3 Years: | 20% |
| Last Year: | 16% |
Last Updated: September 5, 2025, 3:50 am
Balance Sheet
Last Updated: June 16, 2025, 12:10 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 11 | 11 | 11 | 11 | 11 | 10 | 10 | 16 | 16 | 16 | 16 |
| Reserves | 98 | 91 | 98 | 116 | 118 | 128 | 142 | 192 | 379 | 515 | 596 | 620 |
| Borrowings | 12 | 10 | 0 | 0 | 0 | 0 | 0 | 7 | 15 | 26 | 26 | 30 |
| Other Liabilities | 27 | 54 | 73 | 43 | 63 | 53 | 62 | 56 | 185 | 174 | 128 | 165 |
| Total Liabilities | 147 | 165 | 182 | 171 | 191 | 192 | 214 | 264 | 594 | 730 | 765 | 831 |
| Fixed Assets | 27 | 24 | 25 | 27 | 22 | 19 | 26 | 25 | 108 | 142 | 131 | 113 |
| CWIP | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 6 | 5 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 0 |
| Other Assets | 119 | 139 | 157 | 144 | 169 | 173 | 188 | 239 | 480 | 582 | 614 | 719 |
| Total Assets | 147 | 165 | 182 | 171 | 191 | 192 | 214 | 264 | 594 | 730 | 765 | 831 |
Below is a detailed analysis of the balance sheet data for Expleo Solutions Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 16.00 Cr..
- For Reserves, as of Mar 2025, the value is 620.00 Cr.. The value appears strong and on an upward trend. It has increased from 596.00 Cr. (Mar 2024) to 620.00 Cr., marking an increase of 24.00 Cr..
- For Borrowings, as of Mar 2025, the value is 30.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 26.00 Cr. (Mar 2024) to 30.00 Cr., marking an increase of 4.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 165.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 128.00 Cr. (Mar 2024) to 165.00 Cr., marking an increase of 37.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 831.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 765.00 Cr. (Mar 2024) to 831.00 Cr., marking an increase of 66.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 113.00 Cr.. The value appears to be declining and may need further review. It has decreased from 131.00 Cr. (Mar 2024) to 113.00 Cr., marking a decrease of 18.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 5.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 15.00 Cr..
- For Other Assets, as of Mar 2025, the value is 719.00 Cr.. The value appears strong and on an upward trend. It has increased from 614.00 Cr. (Mar 2024) to 719.00 Cr., marking an increase of 105.00 Cr..
- For Total Assets, as of Mar 2025, the value is 831.00 Cr.. The value appears strong and on an upward trend. It has increased from 765.00 Cr. (Mar 2024) to 831.00 Cr., marking an increase of 66.00 Cr..
Notably, the Reserves (620.00 Cr.) exceed the Borrowings (30.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 28.00 | 27.00 | 54.00 | 41.00 | 40.00 | 53.00 | 53.00 | 63.00 | 109.00 | 174.00 | 123.00 | 136.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 105 | 97 | 75 | 60 | 92 | 59 | 103 | 74 | 85 | 97 | 94 | 79 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 105 | 97 | 75 | 60 | 92 | 59 | 103 | 74 | 85 | 97 | 94 | 79 |
| Working Capital Days | 68 | 23 | -7 | 8 | 21 | 15 | 50 | 48 | 46 | 93 | 112 | 67 |
| ROCE % | 40% | 29% | 51% | 31% | 38% | 40% | 38% | 39% | 36% | 39% | 20% | 21% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Invesco India Multicap Fund | 133,972 | 0.66 | 17.73 | 133,972 | 2025-04-22 15:56:58 | 0% |
| Invesco India Smallcap Fund | 127,985 | 0.59 | 16.93 | 127,985 | 2025-04-22 15:56:58 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 66.52 | 58.27 | 86.27 | 52.58 | 49.20 |
| Diluted EPS (Rs.) | 66.52 | 58.27 | 86.27 | 52.58 | 49.20 |
| Cash EPS (Rs.) | 91.85 | 79.96 | 157.79 | 60.32 | 54.86 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 409.69 | 393.78 | 512.06 | 248.93 | 196.90 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 409.69 | 393.78 | 512.06 | 248.93 | 196.90 |
| Revenue From Operations / Share (Rs.) | 660.31 | 621.69 | 881.09 | 394.57 | 293.50 |
| PBDIT / Share (Rs.) | 117.18 | 100.42 | 210.93 | 78.85 | 73.42 |
| PBIT / Share (Rs.) | 91.86 | 78.73 | 183.73 | 71.11 | 67.75 |
| PBT / Share (Rs.) | 89.72 | 77.05 | 181.53 | 70.37 | 66.72 |
| Net Profit / Share (Rs.) | 66.52 | 58.27 | 130.60 | 52.58 | 49.20 |
| NP After MI And SOA / Share (Rs.) | 66.52 | 58.27 | 130.60 | 52.58 | 49.20 |
| PBDIT Margin (%) | 17.74 | 16.15 | 23.93 | 19.98 | 25.01 |
| PBIT Margin (%) | 13.91 | 12.66 | 20.85 | 18.02 | 23.08 |
| PBT Margin (%) | 13.58 | 12.39 | 20.60 | 17.83 | 22.73 |
| Net Profit Margin (%) | 10.07 | 9.37 | 14.82 | 13.32 | 16.76 |
| NP After MI And SOA Margin (%) | 10.07 | 9.37 | 14.82 | 13.32 | 16.76 |
| Return on Networth / Equity (%) | 16.23 | 14.79 | 25.50 | 21.12 | 24.98 |
| Return on Capital Employeed (%) | 20.76 | 18.48 | 33.48 | 27.11 | 33.16 |
| Return On Assets (%) | 12.42 | 11.82 | 18.33 | 15.65 | 19.08 |
| Asset Turnover Ratio (%) | 1.28 | 1.29 | 1.84 | 1.46 | 1.36 |
| Current Ratio (X) | 3.90 | 5.77 | 3.30 | 3.84 | 4.11 |
| Quick Ratio (X) | 3.90 | 5.77 | 3.30 | 3.84 | 4.11 |
| Dividend Payout Ratio (NP) (%) | 75.16 | 8.58 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 54.43 | 6.25 | 0.00 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 24.84 | 91.42 | 0.00 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 45.57 | 93.75 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 54.75 | 59.74 | 95.85 | 106.51 | 71.28 |
| Interest Coverage Ratio (Post Tax) (X) | 32.08 | 35.66 | 60.35 | 72.02 | 48.77 |
| Enterprise Value (Cr.) | 1006.97 | 1697.97 | 1111.70 | 1571.40 | 398.52 |
| EV / Net Operating Revenue (X) | 0.98 | 1.76 | 1.23 | 3.88 | 1.32 |
| EV / EBITDA (X) | 5.54 | 10.89 | 5.14 | 19.44 | 5.29 |
| MarketCap / Net Operating Revenue (X) | 1.21 | 1.95 | 1.40 | 4.27 | 1.76 |
| Retention Ratios (%) | 24.83 | 91.41 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 1.94 | 3.08 | 2.41 | 6.77 | 2.62 |
| Price / Net Operating Revenue (X) | 1.21 | 1.95 | 1.40 | 4.27 | 1.76 |
| EarningsYield | 0.08 | 0.04 | 0.10 | 0.03 | 0.09 |
After reviewing the key financial ratios for Expleo Solutions Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 66.52. This value is within the healthy range. It has increased from 58.27 (Mar 24) to 66.52, marking an increase of 8.25.
- For Diluted EPS (Rs.), as of Mar 25, the value is 66.52. This value is within the healthy range. It has increased from 58.27 (Mar 24) to 66.52, marking an increase of 8.25.
- For Cash EPS (Rs.), as of Mar 25, the value is 91.85. This value is within the healthy range. It has increased from 79.96 (Mar 24) to 91.85, marking an increase of 11.89.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 409.69. It has increased from 393.78 (Mar 24) to 409.69, marking an increase of 15.91.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 409.69. It has increased from 393.78 (Mar 24) to 409.69, marking an increase of 15.91.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 660.31. It has increased from 621.69 (Mar 24) to 660.31, marking an increase of 38.62.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 117.18. This value is within the healthy range. It has increased from 100.42 (Mar 24) to 117.18, marking an increase of 16.76.
- For PBIT / Share (Rs.), as of Mar 25, the value is 91.86. This value is within the healthy range. It has increased from 78.73 (Mar 24) to 91.86, marking an increase of 13.13.
- For PBT / Share (Rs.), as of Mar 25, the value is 89.72. This value is within the healthy range. It has increased from 77.05 (Mar 24) to 89.72, marking an increase of 12.67.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 66.52. This value is within the healthy range. It has increased from 58.27 (Mar 24) to 66.52, marking an increase of 8.25.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 66.52. This value is within the healthy range. It has increased from 58.27 (Mar 24) to 66.52, marking an increase of 8.25.
- For PBDIT Margin (%), as of Mar 25, the value is 17.74. This value is within the healthy range. It has increased from 16.15 (Mar 24) to 17.74, marking an increase of 1.59.
- For PBIT Margin (%), as of Mar 25, the value is 13.91. This value is within the healthy range. It has increased from 12.66 (Mar 24) to 13.91, marking an increase of 1.25.
- For PBT Margin (%), as of Mar 25, the value is 13.58. This value is within the healthy range. It has increased from 12.39 (Mar 24) to 13.58, marking an increase of 1.19.
- For Net Profit Margin (%), as of Mar 25, the value is 10.07. This value exceeds the healthy maximum of 10. It has increased from 9.37 (Mar 24) to 10.07, marking an increase of 0.70.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 10.07. This value is within the healthy range. It has increased from 9.37 (Mar 24) to 10.07, marking an increase of 0.70.
- For Return on Networth / Equity (%), as of Mar 25, the value is 16.23. This value is within the healthy range. It has increased from 14.79 (Mar 24) to 16.23, marking an increase of 1.44.
- For Return on Capital Employeed (%), as of Mar 25, the value is 20.76. This value is within the healthy range. It has increased from 18.48 (Mar 24) to 20.76, marking an increase of 2.28.
- For Return On Assets (%), as of Mar 25, the value is 12.42. This value is within the healthy range. It has increased from 11.82 (Mar 24) to 12.42, marking an increase of 0.60.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.28. It has decreased from 1.29 (Mar 24) to 1.28, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 3.90. This value exceeds the healthy maximum of 3. It has decreased from 5.77 (Mar 24) to 3.90, marking a decrease of 1.87.
- For Quick Ratio (X), as of Mar 25, the value is 3.90. This value exceeds the healthy maximum of 2. It has decreased from 5.77 (Mar 24) to 3.90, marking a decrease of 1.87.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 75.16. This value exceeds the healthy maximum of 50. It has increased from 8.58 (Mar 24) to 75.16, marking an increase of 66.58.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 54.43. This value exceeds the healthy maximum of 50. It has increased from 6.25 (Mar 24) to 54.43, marking an increase of 48.18.
- For Earning Retention Ratio (%), as of Mar 25, the value is 24.84. This value is below the healthy minimum of 40. It has decreased from 91.42 (Mar 24) to 24.84, marking a decrease of 66.58.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 45.57. This value is within the healthy range. It has decreased from 93.75 (Mar 24) to 45.57, marking a decrease of 48.18.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 54.75. This value is within the healthy range. It has decreased from 59.74 (Mar 24) to 54.75, marking a decrease of 4.99.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 32.08. This value is within the healthy range. It has decreased from 35.66 (Mar 24) to 32.08, marking a decrease of 3.58.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,006.97. It has decreased from 1,697.97 (Mar 24) to 1,006.97, marking a decrease of 691.00.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has decreased from 1.76 (Mar 24) to 0.98, marking a decrease of 0.78.
- For EV / EBITDA (X), as of Mar 25, the value is 5.54. This value is within the healthy range. It has decreased from 10.89 (Mar 24) to 5.54, marking a decrease of 5.35.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has decreased from 1.95 (Mar 24) to 1.21, marking a decrease of 0.74.
- For Retention Ratios (%), as of Mar 25, the value is 24.83. This value is below the healthy minimum of 30. It has decreased from 91.41 (Mar 24) to 24.83, marking a decrease of 66.58.
- For Price / BV (X), as of Mar 25, the value is 1.94. This value is within the healthy range. It has decreased from 3.08 (Mar 24) to 1.94, marking a decrease of 1.14.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has decreased from 1.95 (Mar 24) to 1.21, marking a decrease of 0.74.
- For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.08, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Expleo Solutions Ltd:
- Net Profit Margin: 10.07%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 20.76% (Industry Average ROCE: 14.92%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.23% (Industry Average ROE: 20.95%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 32.08
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.9
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 15.8 (Industry average Stock P/E: 143.29)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.07%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | 6A, Sixth Floor, Prince Infocity II, Chennai (Madras) Tamil Nadu 600096 | investor.expleosol@expleogroup.com https://www.investors.expleo.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ralph Franz Gillessen | Chairman & Non-Exe.Director |
| Mr. Phani Tangirala | Managing Director & CEO |
| Mr. Rajesh Krishnamurthy | Non Executive Director |
| Mr. Narayanan Subramaniam | Independent Director |
| Dr. Srivardhini Keshavamurthy Jha | Independent Director |
| Dr. Varadharajan Sridhar | Independent Director |
| Ms. Shalini Kalsi Kamath | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Expleo Solutions Ltd?
Expleo Solutions Ltd's intrinsic value (as of 28 October 2025) is 886.38 which is 12.59% lower the current market price of 1,014.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 1,574 Cr. market cap, FY2025-2026 high/low of 1,567/686, reserves of ₹620 Cr, and liabilities of 831 Cr.
What is the Market Cap of Expleo Solutions Ltd?
The Market Cap of Expleo Solutions Ltd is 1,574 Cr..
What is the current Stock Price of Expleo Solutions Ltd as on 28 October 2025?
The current stock price of Expleo Solutions Ltd as on 28 October 2025 is 1,014.
What is the High / Low of Expleo Solutions Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Expleo Solutions Ltd stocks is 1,567/686.
What is the Stock P/E of Expleo Solutions Ltd?
The Stock P/E of Expleo Solutions Ltd is 15.8.
What is the Book Value of Expleo Solutions Ltd?
The Book Value of Expleo Solutions Ltd is 410.
What is the Dividend Yield of Expleo Solutions Ltd?
The Dividend Yield of Expleo Solutions Ltd is 4.93 %.
What is the ROCE of Expleo Solutions Ltd?
The ROCE of Expleo Solutions Ltd is 21.5 %.
What is the ROE of Expleo Solutions Ltd?
The ROE of Expleo Solutions Ltd is 16.3 %.
What is the Face Value of Expleo Solutions Ltd?
The Face Value of Expleo Solutions Ltd is 10.0.